About us

BioMimics 3D® Vascular Stent System

Events, News & Press

Visit this section

Who we are
Where we're going
Our innovative approach
Veryan people

Visit this section

3D Helical Stent Design
Technical Information
Clinical Evidence
Ordering Information
Health Economics
Our Distributors

Explore our news

Press Releases

U.S.

About us

Who we are

Where we're going

Our innovative approach

Veryan people

Veryan Board

Executive Team

Featured Employee

BioMimics 3D® Vascular Stent System

3D Helical Stent Design

Technical Information

Clinical Evidence

Ordering Information

Health Economics

Our Distributors

Events, News & Press

Press Releases

Home
Events, News & Press
Press Releases
June 2016

Press

POSTED 01 June 2016

June 2016

Significant milestones achieved in Veryan’s MIMICS clinical programme

Download pdf - June 2016 1

TERMS & CONDITIONS

PRIVACY AND COOKIES

UK TAX STATEMENT

About us

Who we are
Where we're going
Our innovative approach
Veryan people

BioMimics 3D® Vascular Stent System

3D Helical Stent Design
Technical Information
Clinical Evidence
Ordering Information
Health Economics
Our Distributors

Events, News & Press

Press Releases

©Veryan Medical 2020

The BioMimics 3D Vascular Stent System has FDA and CE Mark approval.
BioMimics 3D & Swirling Flow Stent are registered trademarks of Veryan Medical Limited.
Not available for sale in Japan.
Veryan Medical Limited is a member of the Otsuka Medical Devices group of companies.
CAUTION: Federal law restricts this device to sale by or on the order of a physician.